AIG
CERE

American International Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

American International Group’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,294
Closed -$1.49M – 2957
2024
Q1 		$1.49M Buy
35,294
+546
+2% +$22.9K 0.01% 1105
2023
Q4 		$1.47M Buy
34,748
+3,865
+13% +$111K 0.01% 1121
2023
Q3 		$674K Buy
30,883
+1,098
+4% +$27.5K ﹤0.01% 1441
2023
Q2 		$947K Buy
29,785
+2,136
+8% +$65.6K 0.01% 1276
2023
Q1 		$674K Buy
27,649
+550
+2% +$16.1K ﹤0.01% 1435
2022
Q4 		$855K Buy
27,099
+1,299
+5% +$36.7K 0.01% 1282
2022
Q3 		$729K Buy
25,800
+365
+1% +$10.9K 0.01% 1361
2022
Q2 		$673K Buy
25,435
+5,209
+26% +$148K ﹤0.01% 1423
2022
Q1 		$708K Sell
20,226
-1,423
-7% -$41.6K ﹤0.01% 1525
2021
Q4 		$702K Sell
21,649
-290
-1% -$10.2K ﹤0.01% 1619
2021
Q3 		$647K Buy
21,939
+2,180
+11% +$61.2K ﹤0.01% 1688
2021
Q2 		$506 Buy
+19,759
New +$283K ﹤0.01% 1912

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

American International Group's CERE Position: Q2 2024 in Review

American International Group sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q2 2024, closing a stake of 35,294 shares — an estimated $1.49M sold.

American International Group first reported a position in CERE in Q2 2021 and held it in 12 quarters. The position peaked at $1.49M in Q1 2024. 231 funds tracked by Wall St. Rank hold CERE as of Q2 2024.

  • American International Group reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 35,294 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q2 2024, an estimated $1.49M.
  • American International Group first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • American International Group's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.49M in Q1 2024.
  • 231 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.